| 62541-201-14 |
62541-201 |
HUMAN PRESCRIPTION DRUG |
Qsymia |
phentermine and topiramate |
CAPSULE, EXTENDED RELEASE |
ORAL |
20120917 |
N/A |
NDA |
NDA022580 |
Vivus LLC |
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE |
3.75 mg/1; 23 mg/1 |
14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-201-14) |
| 62541-201-30 |
62541-201 |
HUMAN PRESCRIPTION DRUG |
Qsymia |
phentermine and topiramate |
CAPSULE, EXTENDED RELEASE |
ORAL |
20120917 |
N/A |
NDA |
NDA022580 |
Vivus LLC |
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE |
3.75 mg/1; 23 mg/1 |
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-201-30) |
| 66993-781-30 |
66993-781 |
HUMAN PRESCRIPTION DRUG |
phentermine and topiramate |
phentermine and topiramate |
CAPSULE, EXTENDED RELEASE |
ORAL |
20250601 |
N/A |
NDA AUTHORIZED GENERIC |
NDA022580 |
Prasco Laboratories |
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE |
7.5 mg/1; 46 mg/1 |
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (66993-781-30) |
| 62541-203-30 |
62541-203 |
HUMAN PRESCRIPTION DRUG |
Qsymia |
phentermine and topiramate |
CAPSULE, EXTENDED RELEASE |
ORAL |
20120917 |
N/A |
NDA |
NDA022580 |
Vivus LLC |
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE |
11.25 mg/1; 69 mg/1 |
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62541-203-30) |
| 66993-783-30 |
66993-783 |
HUMAN PRESCRIPTION DRUG |
phentermine and topiramate |
phentermine and topiramate |
CAPSULE, EXTENDED RELEASE |
ORAL |
20250601 |
N/A |
NDA AUTHORIZED GENERIC |
NDA022580 |
Prasco Laboratories |
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE |
15 mg/1; 92 mg/1 |
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (66993-783-30) |
| 62541-204-30 |
62541-204 |
HUMAN PRESCRIPTION DRUG |
Qsymia |
phentermine and topiramate |
CAPSULE, EXTENDED RELEASE |
ORAL |
20120917 |
N/A |
NDA |
NDA022580 |
Vivus LLC |
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE |
15 mg/1; 92 mg/1 |
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-204-30) |
| 66993-780-30 |
66993-780 |
HUMAN PRESCRIPTION DRUG |
phentermine and topiramate |
phentermine and topiramate |
CAPSULE, EXTENDED RELEASE |
ORAL |
20250601 |
N/A |
NDA AUTHORIZED GENERIC |
NDA022580 |
Prasco Laboratories |
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE |
3.75 mg/1; 23 mg/1 |
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (66993-780-30) |
| 62541-202-30 |
62541-202 |
HUMAN PRESCRIPTION DRUG |
Qsymia |
phentermine and topiramate |
CAPSULE, EXTENDED RELEASE |
ORAL |
20120917 |
N/A |
NDA |
NDA022580 |
Vivus LLC |
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE |
7.5 mg/1; 46 mg/1 |
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-202-30) |
| 66993-782-30 |
66993-782 |
HUMAN PRESCRIPTION DRUG |
phentermine and topiramate |
phentermine and topiramate |
CAPSULE, EXTENDED RELEASE |
ORAL |
20250601 |
N/A |
NDA AUTHORIZED GENERIC |
NDA022580 |
Prasco Laboratories |
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE |
11.25 mg/1; 69 mg/1 |
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66993-782-30) |